LPL and obesity disorder: An inhibitory action of estrogens on lipoprotein lipase has been described to explain the inhibition of obesity development by estrogen replacement therapy in rats [15]; however, we do not have any evidence that support a similar action for the inhibitory effect of OE treatment.